Hasil Pencarian - Brandon Han

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Hydrogen-free Deoxygenation of Waste Cooking Oil over Unreduced Bimetallic NiCo Catalysts for Biojet Fuel Production

    Hydrogen-free Deoxygenation of Waste Cooking Oil over Unreduced Bimetallic NiCo Catalysts for Biojet Fuel Production oleh Brandon Han Hoe Goh, Cheng Tung Chong, Jo-Han Ng

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases

    Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases oleh Irene Rose Antony, Brandon Han Siang Wong, Dermot Kelleher, Navin Kumar Verma

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility

    GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility oleh Mobashar Hussain Urf Turabe Fazil, Praseetha Prasannan, Brandon Han Siang Wong, Brandon Han Siang Wong, Amuthavalli Kottaiswamy, Nur Syazwani Binte Mohamed Salim, Siu Kwan Sze, Navin Kumar Verma

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint

    Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint oleh Navin Kumar Verma, Brandon Han Siang Wong, Zhi Sheng Poh, Aiswarya Udayakumar, Ritu Verma, Ryan Kwang Jin Goh, Shane P. Duggan, Vishalkumar G. Shelat, K. George Chandy, Nicholas Francis Grigoropoulos

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

    Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication oleh Gustavo Garcia, Jr., Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, Mark S. Parcells, Sebastian Beck, Heeyoung Kim, Malina A. Bakowski, Melanie G. Kirkpatrick, Laura Riva, Karen C. Wolff, Brandon Han, Constance Yuen, David Ulmert, Prabhat K. Purbey, Phillip Scumpia, Nathan Beutler, Thomas F. Rogers, Arnab K. Chatterjee, Gülsah Gabriel, Ralf Bartenschlager, Brigitte Gomperts, Clive N. Svendsen, Ulrich A.K. Betz, Robert D. Damoiseaux, Vaithilingaraja Arumugaswami

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

    DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes oleh Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, Brandon Han Siang Wong, Xinpeng Loh, Aik Seng Ng, Zun Siong Low, Praseetha Prasannan, Chun Gong, Michelle Guet Khim Tan, Chandramouli Nagarajan, Dachuan Huang, Pang Wan Lu, Jing Quan Lim, Sharon Barrans, Choon Kiat Ong, Soon Thye Lim, Wee Joo Chng, George Follows, Daniel J. Hodson, Ming Qing Du, Yeow Tee Goh, Suat Hoon Tan, Nicholas Francis Grigoropoulos, Navin Kumar Verma

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: